Impact of Edge to Edge Transcatheter Tricuspid Valve Repair

Reducing tricuspid regurgitation with transcatheter valve repair is associated to improved liver function, which is often ignored by many cardiologists. This is especially true in cases with deteriorated liver function prior valve repair. Instead, kidney function did not show any changes.

Costo efectividad de la reparación endovascular y quirúrgica en aneurismas complejos

Transcatheter tricuspid valve repair seems attractive especially in patients with liver failure.

Edge to edge tricuspid valve repair emerged an alternative for inoperable patients, or even all patients, since surgical repair is associated with suboptimal results when it comes to repairing or replacing this valve. Always in the shadow of the aortic and mitral valves, tricuspid failure has significant impact on organs long ignored by many cardiologists (for instance the liver).


Read also: Surgery to Improve Survival in Isolated Tricuspid Regurgitation.


The study included 126 patients treated in a transcatheter repair center between 2016 and 2018. Baseline liver and kidney functions were registered and compared against 30-day and 6-month outcomes.

110 patients survived 6 months after procedure. Among them, kidney function remained stable, including that of patients with moderate to severe chronic kidney failure (baseline glomerular filtration 37.5 ml/min/1.73m² vs 40.1 ml/min/1.73m² at 6 months; p=0.39).

As regards liver function, there was significant improvement at 6 months, observed in transaminase and bilirubin levels. The poorer the baseline function, the more it improved.

Conclusion

Reducing tricuspid regurgitation with transcatheter edge to edge repair is associated with significantly improved liver function, while kidney failure remains stable compared to baseline.

This option appears more and more attractive for inoperable patients or even all patients.

Original Title: Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function.

Reference: Nicole Karam et al. J Am Coll Cardiol Intv 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...